• Claim your 1.0hr CE/CME Credit Here

  • What best describes your title?*
  • If MD/DO
  • If RN/NP
  • If PharmD
  • Where are you based?
  • How did you FIRST hear about our tweetorials?
  • 1. Iberdomide & mezigdomide are best described as:*
  • 2. In late-line RRMM, iberdomide+dex and mezigdomide+dex most commonly require monitoring/support for:*
  • 3. Which statement is accurate for CELMoDs in heavily pretreated RRMM?*
  • 4. Did you follow the entire tweetorial?*
  • 5. Did you find this to be an effective learning tool?*
  • 7. How will this program change your practice?*
  • 8. Will you recommend @ONC_CE and/or this website to your colleagues?*
  •  - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: